Third-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse model

Molecular Therapy

Volumn 21, Issue 9, 2013, Pages 1778-1786

  Wu, Hao ^a   Wen, Di ^a   Mahato, Ram I ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CD14 ANTIGEN; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GRAFT REJECTION; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; LOSS OF FUNCTION MUTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MITOSIS INHIBITION; MONOCYTE; MOUSE; MOUSE STRAIN; NOD SCID GAMMA MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS ISLET TRANSPLANTATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; STREPTOZOCIN DIABETES; T LYMPHOCYTE ACTIVATION;

MUS;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LEUKOCYTES, MONONUCLEAR; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; T-LYMPHOCYTES, REGULATORY;

EID: 84883741798     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.147     Document Type: Article

References (34)

1. Narang, AS and Mahato, RI (2006). Biological and biomaterial approaches for improved islet transplantation. Pharmacol Rev 58: 194-243.
2. Mahato, RI, Henry, J, Narang, AS, Sabek, O, Fraga, D, Kotb, M et al. (2003). Cationic lipid and polymer-based gene delivery to human pancreatic islets. Mol Ther 7: 89-100. (Pubitemid 36305362)
3. Wu, H, Ye, Z and Mahato, RI (2011). Genetically modified mesenchymal stem cells for improved islet transplantation. Mol Pharm 8: 1458-1470.
4. Inoue, S, Popp, FC, Koehl, GE, Piso, P, Schlitt, HJ, Geissler, EK et al. (2006). Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 81: 1589-1595. (Pubitemid 43890897)
5. Pittenger, MF, Mackay, AM, Beck, SC, Jaiswal, RK, Douglas, R, Mosca, JD et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. (Pubitemid 29282067)
6. Ryan, JM, Barry, FP, Murphy, JM and Mahon, BP (2005). Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2: 8.
7. Hematti, P (2008). Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev (Orlando) 22: 262-273.
8. Ding, Y, Xu, D, Feng, G, Bushell, A, Muschel, RJ and Wood, KJ (2009). Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and-9. Diabetes 58: 1797-1806.
9. Yeung, TY, Seeberger, KL, Kin, T, Adesida, A, Jomha, N, Shapiro, AM et al. (2012). Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLoS ONE 7: e38189.
10. Ito, T, Itakura, S, Todorov, I, Rawson, J, Asari, S, Shintaku, J et al. (2010). Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function. Transplantation 89: 1438-1445.
11. Dhodapkar, MV, Steinman, RM, Krasovsky, J, Munz, C and Bhardwaj, N (2001). Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193: 233-238. (Pubitemid 32524454)
12. Wu, H, Lu, W and Mahato, RI (2011). Mesenchymal stem cells as a gene delivery vehicle for successful islet transplantation. Pharm Res 28: 2098-2109.
13. Mazar, J, Thomas, M, Bezrukov, L, Chanturia, A, Pekkurnaz, G, Yin, S et al. (2009). Cytotoxicity mediated by the Fas ligand (FasL)-activated apoptotic pathway in stem cells. J Biol Chem 284: 22022-22028.
14. Di Nicola, M, Carlo-Stella, C, Magni, M, Milanesi, M, Longoni, PD, Matteucci, P et al. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843. (Pubitemid 34534559)
15. Brehm, MA, Shultz, LD and Greiner, DL (2010). Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes 17: 120-125.
16. Issa, F, Hester, J, Goto, R, Nadig, SN, Goodacre, TE and Wood, K (2010). Ex vivoexpanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation 90: 1321-1327.
17. Zhang, B, Liu, R, Shi, D, Liu, X, Chen, Y, Dou, X et al. (2009). Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood 113: 46-57.
18. Weng, J, He, C, Lai, P, Luo, C, Guo, R, Wu, S et al. (2012). Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease. Mol Ther 20: 2347-2354.
19. Chen, LB, Jiang, XB and Yang, L (2004). Differentiation of rat marrow mesenchymal stem cells into pancreatic islet ?-cells. World J Gastroenterol 10: 3016-3020. (Pubitemid 39303055)
20. Karnieli, O, Izhar-Prato, Y, Bulvik, S and Efrat, S (2007). Generation of insulinproducing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 25: 2837-2844. (Pubitemid 350127868)
21. Koina ON, Gerson, SL, Cooper, BW, Dyhouse, SM, Haynesworth, SE, Caplan, AI et al. (2000). Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18: 307-316. (Pubitemid 30056419)
22. Chan, JL, Tang, KC, Patel, AP, Bonilla, LM, Pierobon, N, Ponzio, NM et al. (2006). Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-?. Blood 107: 4817-4824. (Pubitemid 43882633)
23. Lodie, TA, Blickarz, CE, Devarakonda, TJ, He, C, Dash, AB, Clarke, J et al. (2002). Systematic analysis of reportedly distinct populations of multipotent bone marrowderived stem cells reveals a lack of distinction. Tissue Eng 8: 739-751. (Pubitemid 35239752)
24. Sato, H, Kuwashima, N, Sakaida, T, Hatano, M, Dusak, JE, Fellows-Mayle, WK et al. (2005). Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors. Cancer Gene Ther 12: 757-768. (Pubitemid 41208615)
25. Rasmusson, I, Ringd, O, Sundberg, B and Le Blanc, K (2005). Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 305: 33-41. (Pubitemid 40380651)
26. Beyth, S, Borovsky, Z, Mevorach, D, Liebergall, M, Gazit, Z, Aslan, H et al. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105: 2214-2219. (Pubitemid 40731815)
27. Groh, ME, Maitra, B, Szekely, E and Koina ON (2005). Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 33: 928-934. (Pubitemid 40982660)
28. Jiang, XX, Zhang, Y, Liu, B, Zhang, SX, Wu, Y, Yu, XD et al. (2005). Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105: 4120-4126. (Pubitemid 40656164)
29. Spaggiari, GM, Capobianco, A, Abdelrazik, H, Becchetti, F, Mingari, MC and Moretta, L (2008). Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111: 1327-1333. (Pubitemid 351213419)
30. Boumaza, I, Srinivasan, S, Witt, WT, Feghali-Bostwick, C, Dai, Y, Garcia-Ocana, A et al. (2009). Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia. J Autoimmun 32: 33-42.
31. Franis, M, Romieu-Mourez, R, Li, M and Galipeau, J (2012). Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther 20: 187-195.
32. Brehm, MA, Bortell, R, Diiorio, P, Leif, J, Laning, J, Cuthbert, A et al. (2010). Human immune system development and rejection of human islet allografts in spontaneously diabetic NOD-Rag1null IL2r?null Ins2Akita mice. Diabetes 59: 2265-2270.
33. Harui, A, Kiertscher, SM and Roth, MD (2011). Reconstitution of huPBL-NSG mice with donor-matched dendritic cells enables antigen-specific T-cell activation. J Neuroimmune Pharmacol 6: 148-157.
34. Garcia-Ocana, A, Takane, KK, Reddy, VT, Lopez-Talavera, JC, Vasavada, RC and Stewart, AF (2003). Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces cell death. J Biol Chem 278: 343-351. (Pubitemid 36043582)